Sivik Global Healthcare LLC

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 20, 2026), Sivik Global Healthcare LLC reported 34 stock positions worth $131.7 million. Its top holding was SS SPDR S&P Biotech ETF (XBI) at 14.5% of the portfolio, followed by Cardinal Health (CAH, 3.9%) and Call- BSX 100 @ 75 Exp 04/17/2026 (3.8%). Its holdings were unchanged from Q1 2026.

Most Recent 13F
Q2 2026
Location
GREENWICH, CT
CIK
0001596452
Portfolio Value
$131.7M (Q2 2026)
SEC Filing
0001596452-26-000004 ↗ filed Jul 20, 2026

Holdings Value

0$100.0M$200.0M$300.0M Q1 2024: $275.1M Q1 2024 Q2 2024: $223.9M Q2 2024 Q3 2024: $234.6M Q3 2024 Q4 2024: $180.8M Q4 2024 Q1 2025: $182.9M Q1 2025 Q2 2025: $223.6M Q2 2025 Q3 2025: $190.5M Q3 2025 Q4 2025: $204.8M Q4 2025 Q1 2026: $131.7M Q1 2026 Q2 2026: $131.7M $131.7M Q2 2026

Holdings 34 stocks · $131.7M

XBI SS SPDR S&P Biotech ETF 14.55% 150,000 $19.2M No change
CAH Cardinal Health Inc. 3.85% 24,000 $5.1M No change
CALL- BSX 100 @ 75 EXP 04/17/2026 3.81% 800 $5.0M No change
JNJ Johnson & Johnson 3.71% 20,000 $4.9M No change
MRK Merck & Co. Inc. 3.65% 40,000 $4.8M No change
COR Cencora Inc. 3.58% 15,000 $4.7M No change
LLY Eli Lilly & Co. 3.49% 5,000 $4.6M No change
WAT Waters Corp. 3.39% 15,000 $4.5M No change
VRTX Vertex Pharmaceuticals Inc. 3.39% 10,000 $4.5M No change
ISRG Intuitive Surgical Inc. 3.15% 9,000 $4.1M No change
AZN Astrazeneca PLC 3.00% 20,000 $3.9M No change
TMO Thermo Fisher Scientific Inc. 2.99% 8,000 $3.9M No change
BSX Boston Scientific Corp. 2.95% 62,000 $3.9M No change
DHR Danaher Corp. 2.88% 20,000 $3.8M No change
THC Tenet Healthcare Corp. 2.87% 20,000 $3.8M No change
GILD Gilead Sciences Inc. 2.65% 25,000 $3.5M No change
HUM Humana Inc. 2.63% 20,000 $3.5M No change
MTD Mettler-Toledo International 2.63% 2,750 $3.5M No change
MCK McKesson Corp. 2.63% 4,000 $3.5M No change
A Agilent Technologies Inc. 2.60% 30,000 $3.4M No change
SYK Stryker Corp. 2.50% 10,000 $3.3M No change
ABBV Abbvie Inc. 2.48% 15,000 $3.3M No change
UHS Universal Health Services-B 2.38% 17,500 $3.1M No change
REGN Regeneron Pharmaceuticals 2.35% 4,000 $3.1M No change
BIO Bio-Rad Laboratories-A 2.12% 10,000 $2.8M No change
BIIB Biogen Inc. 2.09% 15,000 $2.8M No change
UNH Unitedhealth Group Inc. 2.05% 10,000 $2.7M No change
GMED Globus Medical Inc. Class A 1.96% 30,000 $2.6M No change
ABT Abbott Laboratories 1.95% 25,000 $2.6M No change
EW Edwards Lifesciences Corp. 1.22% 20,000 $1.6M No change
SNN Smith & Nephew PLC -Spon ADR 1.21% 50,000 $1.6M No change
ELV Elevance Health Inc. 1.11% 5,000 $1.5M No change
EHC Encompass Health Corp. 1.10% 15,000 $1.5M No change
CVS CVS Health Corp. 1.09% 20,000 $1.4M No change

Portfolio Sells Q1 2026 → Q2 2026

None this quarter.

Portfolio Buys Q1 2026 → Q2 2026

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 34$131.7MXBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK
Q1 2026 34$131.7MXBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK
Q4 2025 41$204.8MXBI, LLY, THC, MCK, HCA
Q3 2025 35$190.5MXBI, LLY, HCA, THC, DHR
Q2 2025 38$223.6MXBI, THC, HCA, MCK, UHS
Q1 2025 29$182.9MXBI, BSX, THC, HCA, LLY
Q4 2024 36$180.8MXBI, LLY, BSX, MCK, SYK
Q3 2024 33$234.6MXBI, LLY, THC, NVO, UHS
Q2 2024 37$223.9MLLY, NVO, MCK, THC, BSX
Q1 2024 46$275.1MXBI, LLY, NVO, BSX, TMO